These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22982967)

  • 1. Transforming growth factor-β1 level and outcome after catheter ablation for nonparoxysmal atrial fibrillation.
    Wu CH; Hu YF; Chou CY; Lin YJ; Chang SL; Lo LW; Tuan TC; Li CH; Chao TF; Chung FP; Liao JN; Chen SA
    Heart Rhythm; 2013 Jan; 10(1):10-5. PubMed ID: 22982967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connective tissue growth factor: a predictor of recurrence after catheter ablation in patients with nonparoxysmal atrial fibrillation.
    Song ZP; Liu X; Zhang DD
    Pacing Clin Electrophysiol; 2014 May; 37(5):630-7. PubMed ID: 24467520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of serum TGF-β1 level in atrial fibrosis and outcome after catheter ablation for paroxysmal atrial fibrillation.
    Tian Y; Wang Y; Chen W; Yin Y; Qin M
    Medicine (Baltimore); 2017 Dec; 96(51):e9210. PubMed ID: 29390467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy.
    Canpolat U; Oto A; Hazirolan T; Sunman H; Yorgun H; Şahiner L; Kaya EB; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Mar; 26(3):251-9. PubMed ID: 25366936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Transforming Growth Factor-β
    Kishima H; Mine T; Takahashi S; Ashida K; Ishihara M; Masuyama T
    J Cardiovasc Electrophysiol; 2017 Apr; 28(4):402-409. PubMed ID: 28127812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and significance of very early recurrence of atrial fibrillation after catheter ablation.
    Chang SL; Tsao HM; Lin YJ; Lo LW; Hu YF; Tuan TC; Suenari K; Tai CT; Li CH; Chao TF; Lin YK; Tsai CF; Wu TJ; Chen SA
    J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1193-8. PubMed ID: 21615812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of catheter ablation in patients with nonparoxysmal atrial fibrillation: results of 3-year follow-up.
    Chao TF; Tsao HM; Lin YJ; Tsai CF; Lin WS; Chang SL; Lo LW; Hu YF; Tuan TC; Suenari K; Li CH; Hartono B; Chang HY; Ambrose K; Wu TJ; Chen SA
    Circ Arrhythm Electrophysiol; 2012 Jun; 5(3):514-20. PubMed ID: 22550126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left atrial strain is a powerful predictor of atrial fibrillation recurrence after catheter ablation: study of a heterogeneous population with sinus rhythm or atrial fibrillation.
    Yasuda R; Murata M; Roberts R; Tokuda H; Minakata Y; Suzuki K; Tsuruta H; Kimura T; Nishiyama N; Fukumoto K; Aizawa Y; Tanimoto K; Takatsuki S; Abe T; Fukuda K
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):1008-14. PubMed ID: 25750193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 4q25 variants and biomarkers of myocardial fibrosis in patients with atrial fibrillation.
    Choi JI; Baek YS; Roh SY; Piccini JP; Kim YH
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1904-1913. PubMed ID: 31393025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left atrial appendage wall-motion velocity associates with recurrence of nonparoxysmal atrial fibrillation after catheter ablation.
    Ariyama M; Kato R; Matsumura M; Yoshimoto H; Nakajima Y; Nakano S; Kasai T; Tanno J; Senbonmatsu T; Matsumoto K; Nishimura S
    Echocardiography; 2015 Feb; 32(2):272-80. PubMed ID: 24919546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling.
    Pump A; Di Biase L; Price J; Mohanty P; Bai R; Santangeli P; Mohanty S; Trivedi C; Yan RX; Horton R; Sanchez JE; Zagrodzky J; Bailey S; Gallinghouse GJ; Burkhardt JD; Natale A
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1224-31. PubMed ID: 24020717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QTc Interval Prolongation Predicts Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
    Wen SN; Liu N; Li SN; Wu XY; Salim M; Kang JP; Ning M; Wu JH; Ruan YF; Yu RH; Long DY; Tang RB; Sang CH; Jiang CX; Bai R; Du X; Dong JZ; Liu XH; Ma CS
    Circ J; 2015; 79(5):1024-30. PubMed ID: 25739859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation.
    den Uijl DW; Delgado V; Bertini M; Tops LF; Trines SA; van de Veire NR; Zeppenfeld K; Schalij MJ; Bax JJ
    Heart; 2011 Nov; 97(22):1847-51. PubMed ID: 21357370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of catheter ablation in patients with atrial fibrillation originating from nonpulmonary vein ectopy.
    Chang HY; Lo LW; Lin YJ; Chang SL; Hu YF; Li CH; Chao TF; Chung FP; Ha TL; Singhal R; Chong E; Yin WH; Tsao HM; Hsieh MH; Chen SA
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):250-8. PubMed ID: 23210627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.
    Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune T; Kofune M; Nagashima K; Mano H; Sonoda K; Kasamaki Y; Hirayama A
    J Cardiovasc Electrophysiol; 2011 Sep; 22(9):987-93. PubMed ID: 21489023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial deformation imaging with ultrasound based two-dimensional speckle-tracking predicts the rate of recurrence of paroxysmal and persistent atrial fibrillation after successful ablation procedures.
    Hammerstingl C; Schwekendiek M; Momcilovic D; Schueler R; Sinning JM; Schrickel JW; Mittmann-Braun E; Nickenig G; Lickfett L
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):247-55. PubMed ID: 21955059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.
    Mohanty S; Mohanty P; Di Biase L; Bai R; Pump A; Santangeli P; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
    J Am Coll Cardiol; 2012 Apr; 59(14):1295-301. PubMed ID: 22464257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting favourable outcomes in the setting of radiofrequency catheter ablation of long-standing persistent atrial fibrillation: a pilot study assessing the value of left atrial appendage peak flow velocity.
    Combes S; Jacob S; Combes N; Karam N; Chaumeil A; Guy-Moyat B; Treguer F; Deplagne A; Boveda S; Marijon E; Albenque JP
    Arch Cardiovasc Dis; 2013 Jan; 106(1):36-43. PubMed ID: 23374970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of TGF-β/periostin in fibrosis of right atrial appendages in patients with atrial fibrillation.
    Wu H; Xie J; Li GN; Chen QH; Li R; Zhang XL; Kang LN; Xu B
    Int J Clin Exp Pathol; 2015; 8(6):6859-69. PubMed ID: 26261573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.